Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 19Genitourinary 14Gastrointestinal 14Breast 14Thoracic 7Lymphoid 6Head & Neck 6Sarcoma 5Gynecologic 5Plasma cell 4Myeloid 3Dermatologic 3Other solid neoplasm 2Endocrine 1Classical hematology 1CNS 1

Conditions

Pituitary Neoplasms 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Reverse Transcriptase Polymerase Chain Reaction × Endocrine × Clear all
NCT00852501 2013-04-09

Characterization of Receptors in Non-functioning Pituitary Macroadenomas

Cook County Health

Unknown
100 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡